G. Landis
Vermögen: 607 079 $ am 30.06.2026
Vermögen: 607 079 $ am 30.06.2026
G.
Michael Landis is Chief Financial Officer & Director at Polaryx Therapeutics, Inc. since 2025.
Former roles include Chief Accounting Officer at Lannett Co., Inc. from 2009 to 2013, Chief Financial Officer at Avisa Diagnostics, Inc. in 2021, and Chief Accounting Officer at Allied Security Holdings LLC.
Also served as Chief Financial Officer at Epygenix Therapeutics, Inc. Education includes undergraduate studies at Franklin & Marshall College.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 18.02.2026 | 228.225 ( 0,48 % ) | 607 079 $ | 30.06.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| POLARYX THERAPEUTICS, INC. | Finanzdirektor/CFO | 01.06.2024 |
| Unternehmen | Position | Ende |
|---|---|---|
| AVISA DIAGNOSTICS INC. | Finanzdirektor/CFO | 01.12.2021 |
| LANNETT COMPANY, INC. | Comptroller/Controller/Auditor | 13.07.2020 |
Epygenix Therapeutics, Inc.
Epygenix Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for neurological disorders | Finanzdirektor/CFO | - |
Allied Security Holdings LLC
Allied Security Holdings LLC Miscellaneous Commercial ServicesCommercial Services Provides security guards and patrol services | Comptroller/Controller/Auditor | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 6 |
|---|---|
Lannett Co., Inc.
Lannett Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures and supplies generic pharmaceutical products | Health Technology |
Allied Security Holdings LLC
Allied Security Holdings LLC Miscellaneous Commercial ServicesCommercial Services Provides security guards and patrol services | Commercial Services |
Franklin & Marshall College
Franklin & Marshall College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Epygenix Therapeutics, Inc.
Epygenix Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for neurological disorders | Health Technology |
Polaryx Therapeutics, Inc.
Polaryx Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biotechnology company that engages in discovery, development and commercialization of novel, disease-modifying therapies for rare, pediatric lysosomal storage disorders | Commercial Services |
Avisa Diagnostics, Inc.
Avisa Diagnostics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen